Intracranial atherosclerotic disease
- PMID: 30439443
- PMCID: PMC6363839
- DOI: 10.1016/j.nbd.2018.11.008
Intracranial atherosclerotic disease
Abstract
Intracranial atherosclerosis (ICAS) is a progressive pathological process that causes progressive stenosis and cerebral hypoperfusion and is a major cause of stroke occurrence and recurrence around the world. Multiple factors contribute to the development of ICAS. Angiography imaging techniques can improve the diagnosis of and the selection of appropriate treatment regimens for ICAS. Neither aggressive medication nor endovascular interventions can eradicate stroke recurrence in patients with ICAS. Non-pharmacological therapies such as remote ischemic conditioning and hypothermia are emerging. Comprehensive therapy with medication in combination with endovascular intervention and/or non-pharmacological treatment may be a potential strategy for ICAS treatment in the future. We summarized the epidemiology, pathophysiological mechanisms, risk factors, biomarkers, imaging and management of ICAS.
Keywords: Angiography; Biomarker; Diagnosis; Intracranial atherosclerosis; Ischemic conditioning; Treatment.
Copyright © 2018. Published by Elsevier Inc.
Conflict of interest statement
Conflict of interest
All authors have no actual or potential conflict of interest including any financial, personal or other relationships with other people or organizations within three years of beginning of the submitted work.
Figures
Similar articles
-
Determinants and Outcomes of Asymptomatic Intracranial Atherosclerotic Stenosis.J Am Coll Cardiol. 2021 Aug 10;78(6):562-571. doi: 10.1016/j.jacc.2021.05.041. J Am Coll Cardiol. 2021. PMID: 34353533 Free PMC article.
-
Concomitant Asymptomatic Intracranial Atherosclerotic Stenosis Increase the 30-Day Risk of Stroke in Patients Undergoing Symptomatic Intracranial Atherosclerotic Stenosis Stenting.J Stroke Cerebrovasc Dis. 2018 Feb;27(2):479-485. doi: 10.1016/j.jstrokecerebrovasdis.2017.09.032. Epub 2017 Oct 19. J Stroke Cerebrovasc Dis. 2018. PMID: 29056405
-
Prevalence and Procedural Risk of Intracranial Atherosclerotic Stenosis Coexisting With Unruptured Intracranial Aneurysm.Stroke. 2023 Jun;54(6):1484-1493. doi: 10.1161/STROKEAHA.122.041553. Epub 2023 May 4. Stroke. 2023. PMID: 37139814 Clinical Trial.
-
Collateral Flow in Intracranial Atherosclerotic Disease.Transl Stroke Res. 2023 Feb;14(1):38-52. doi: 10.1007/s12975-022-01042-3. Epub 2022 Jun 8. Transl Stroke Res. 2023. PMID: 35672561 Review.
-
Intracranial atherosclerotic stenosis: risk factors, diagnosis, and treatment.Lancet Neurol. 2022 Apr;21(4):355-368. doi: 10.1016/S1474-4422(21)00376-8. Epub 2022 Feb 7. Lancet Neurol. 2022. PMID: 35143758 Review.
Cited by
-
Neutrophil-to-Lymphocyte Ratio as a Predictive Biomarker for Stroke Severity and Short-Term Prognosis in Acute Ischemic Stroke With Intracranial Atherosclerotic Stenosis.Front Neurol. 2021 Jul 29;12:705949. doi: 10.3389/fneur.2021.705949. eCollection 2021. Front Neurol. 2021. PMID: 34393983 Free PMC article.
-
Molecular Biomarkers Associated with Early-Onset Symptomatic Intracranial Atherosclerosis.Clin Interv Aging. 2021 Jun 1;16:1013-1022. doi: 10.2147/CIA.S309945. eCollection 2021. Clin Interv Aging. 2021. PMID: 34103904 Free PMC article.
-
Effects of intracranial artery stenosis of anterior circulation on cognition-A CT perfusion-based study.Brain Behav. 2024 Sep;14(9):e3521. doi: 10.1002/brb3.3521. Brain Behav. 2024. PMID: 39236078 Free PMC article.
-
The role of intracranial artery calcification (IAC) in stroke subtype and risk of vascular events.J Stroke Cerebrovasc Dis. 2023 Aug;32(8):107185. doi: 10.1016/j.jstrokecerebrovasdis.2023.107185. Epub 2023 May 13. J Stroke Cerebrovasc Dis. 2023. PMID: 37186970 Free PMC article.
-
Evaluation of peripapillary retinal nerve fiber layer thickness in intracranial atherosclerotic stenosis.BMC Ophthalmol. 2023 Nov 13;23(1):455. doi: 10.1186/s12886-023-03196-6. BMC Ophthalmol. 2023. PMID: 37957614 Free PMC article.
References
-
- Alberti KG, et al., 2009. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120, 1640–1645. 10.1161/circulationaha.109.192644. - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical